Quantcast
Browsing all 27 articles
Browse latest View live

Lung Cancer Stem Cell Finding Could Accelerate Immunotherapy Research

University of Cincinnati researchers have found a way to isolate lung cancer stem cells that evade the immune system, resist chemotherapy and cause tumors to grow and spread. The finding is expected to...

View Article


Lung Transplants Could Increase After UCLA Finds Success with New Technology

A potential option for lung cancer and asbestosis patients, life-saving lung transplants could be easier to get after UCLA has success with the latest technology.

View Article


The ‘Gentler’ Chemotherapy Regimen for Mesothelioma

Researchers explored the risk-benefit ratios of two major mesothelioma chemotherapy regimens: pemetrexed + cisplatin and pemetrexed + carboplatin. They found one of the combinations to pose a lower...

View Article

NCI Researchers Introduce New Personalized Survival Calculator for Peritoneal...

NCI researchers recently created a personalized survival calculator for peritoneal mesothelioma patients. The nomogram - which is based on personal, laboratory and surgical factors - helps predict...

View Article

Mesothelioma Research: Where 2012 Took Us, and What 2013 Has in Store

In December's Journal of Thoracic Oncology, expert oncologist Anne Tsao analyzed recent mesothelioma research developments, including discoveries of anti-angiogenic drugs, immunotherapy procedures and...

View Article


Chemotherapy Drug Alimta was Sparked by the Wings of a Butterfly

Edward Taylor, the Princeton University chemist whose discovery led to Alimta, will be honored by the National Academy of Sciences.

View Article

Verastem Inc. to Begin Developing Novel Mesothelioma Drug

Biopharmaceutical company Verastem, Inc. is gearing up for a phase II mesothelioma trial of a new drug, VS-6063. The drug has been in development for several years and shows promise in mesothelioma...

View Article

Could Fowlpox Vaccination Be Next Big Mesothelioma Treatment?

Researchers at the University of Hawaii found that a fowlpox-based vaccine could be the next promising form of mesothelioma immunotherapy. In an animal study, the vaccine generated a significant immune...

View Article


Latest Experimental Cancer Treatment Drug Reolysin Causing Stir in Financial...

It takes years for new cancer-fighting drugs to reach the market, but the stock market already believes that Reolysin could be next big cancer-treatment drug.

View Article


Recent Observations in End-of-Life Mesothelioma Care

A recent Australian study tracked the treatment choices that mesothelioma patients made in the last month of their care. Although most patients initially received potentially curative treatment, most...

View Article

Sequestration Will Hurt Mesothelioma Research, Drug Development

The federal government spends $5 billion a year on cancer research, but that figure will drop if sequestration cuts are enacted at the end of February, health care experts say. The already low...

View Article

Study Indicates Mesothelioma Surgery May Make Breathing More Difficult

A new study found that mesothelioma patients lost lung volume - and had a harder time breathing - after an extrapleural pneumonectomy.

View Article

Medicare Study Finds No Change in Survival Rates from Higher-Priced Cancer Care

Longer hospital stays raise the price of cancer care, but they don't change survival rates for Medicare patients.

View Article


Cancer Research Producing New Drugs, More Treatment Options

New drugs for mesothelioma treatment emerged from the American Association for Cancer Research Conference in Washington, D.C.

View Article

Mesothelioma Research in Australia Focuses on Blocking Protein Growth

Researchers at Flinders University in Australia focus on the latest mesothelioma treatment.

View Article


Lung Cancer Treatment May Improve with New Chemotherapy Delivery System

Recent research shows that a new delivery method can make chemotherapy more effective for lung cancer and possibly mesothelioma.

View Article

Angeles Clinic and Research Institute Opens Mesothelioma-Specific Clinical Trial

A new Phase 2 clinical trial at the Angeles Clinic will study tremelimumab as an immunotherapy treatment for pleural and peritoneal mesothelioma.

View Article


UK Doctors Question Benefits of EPP Surgery for Mesothelioma Patients

A group of doctors in the United Kingdom is questioning the continuation of EPP surgery for mesothelioma patients.

View Article

Mesothelioma Cancer Patients Hurt by Court Ruling Against Medicinal Marijuana

Recent appeals court ruling on marijuana becomes setback for mesothelioma cancer patients looking for alternative treatment options.

View Article

Could Fowlpox Vaccination Be Next Big Mesothelioma Treatment?

Researchers at the University of Hawaii found that a fowlpox-based vaccine could be the next promising form of mesothelioma immunotherapy.

View Article
Browsing all 27 articles
Browse latest View live